Stockscreener 앱 받기
1.825
6.43%
0.115
전일 마감가:
$1.71
열려 있는:
$1.79
하루 거래량:
1.67M
Relative Volume:
0.93
시가총액:
$122.58M
수익:
-
순이익/손실:
$-13.14M
주가수익비율:
-5.9719
EPS:
-0.3056
순현금흐름:
$-13.11M
1주 성능:
+5.20%
1개월 성능:
-17.28%
6개월 성능:
-20.53%
1년 성능:
-31.58%
1일 변동 폭
$1.78
$1.8899
1주일 범위
$1.68
$1.8899
52주 변동 폭
$1.6001
$4.67
Microbot Medical Inc Stock (MBOT) Company Profile
명칭
Microbot Medical Inc
전화
908-938-5561
주소
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
1.825 | 114.85M | 0 | -13.14M | -13.11M | -0.3056 |
ISRG
Intuitive Surgical Inc
|
436.25 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
146.68 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.31 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.46 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
209.38 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-10 | 개시 | B. Riley Securities | Buy |
| 2025-12-03 | 개시 | Roth Capital | Buy |
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-31 | 개시 | Ladenburg Thalmann | Buy |
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Microbot Medical receives Israel approval for robotic system By Investing.com - Investing.com Canada
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times
[8-K] Microbot Medical Inc. Reports Material Event - Stock Titan
Israel clears single-use LIBERTY vascular robot, opening new markets - Stock Titan
After plunging 22.6% in 4 weeks, here's why the trend might reverse for Microbot Medical (MBOT) - MSN
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT) - Yahoo Finance
Microbot Medical Inc stock (US5950101098): Liberty launch drives first-quarter revenue and raises in - AD HOC NEWS
Microbot Medical Inc. (MBOT) reports Q1 loss, misses revenue estimates - MSN
Microbot Medical stock (US5950101098): Cash runway, pipeline, and what investors are watching - AD HOC NEWS
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Microbot Medical Inc stock (US5950101098): LIBERTY call and Q1 2026 numbers keep focus on robot-assi - AD HOC NEWS
Microbot Medical Schedules Call on LIBERTY System Progress - TipRanks
Microbot Medical to Host May 18 Call Addressing LIBERTY FMR Progress and Third‑Party Article - TradingView
Microbot Medical (NASDAQ: MBOT) sets investor call on LIBERTY progress and recent article - Stock Titan
Microbot Medical to host call addressing recent claims and progress of LIBERTY robotic system - Pluang
Microbot Medical Inc. to Host Conference Call Addressing Misrepresentations from Unaffiliated Third-Party Article - Quiver Quantitative
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu - The Manila Times
Doctors using Microbot’s LIBERTY robot to address article claims - Stock Titan
Microbot Medical (MBOT) Reports Q1 Loss and Faces Short Seller S - GuruFocus
Microbot Medical (MBOT) Faces Stock Plunge Amid Short Seller Rep - GuruFocus
Microbot Medical Inc stock (US5950101098): shares under pressure after short-seller report and weak - AD HOC NEWS
Microbot Medical plunges amid results, short report from White Diamond Research - MSN
Microbot Medical Reports First Revenue from LIBERTY System as Commercial Adoption Accelerates Across U.S. Hospitals 1 - Minichart
Microbot Medical stock drops after White Diamond short report By Investing.com - Investing.com Australia
Microbot Medical stock drops after White Diamond short report - Investing.com
Microbot Medical Launches Full Commercial LIBERTY System Rollout - TipRanks
Microbot Medical Q2 revenue surpasses Q1 after system launch - Investing.com
Microbot Medical Q2 revenue surpasses Q1 after system launch By Investing.com - Investing.com Australia
Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System - TradingView
Microbot Medical records Q1 revenue; Q2 mid-quarter revenue already exceeds Q1 as LIBERTY adoption grows - TradingView
Microbot Medical (NASDAQ: MBOT) sees LIBERTY system revenue rise in Q2 - Stock Titan
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 - GlobeNewswire
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Microbot Medical Inc. (MBOT) latest stock news and headlines - Yahoo Finance Singapore
Microbot Medical Inc. 1Q 2026: Revenue $105K, Net income $(3.67M) — 10-Q Summary - TradingView
Microbot Medical (NASDAQ: MBOT) starts LIBERTY robot sales with strong cash - Stock Titan
Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
TradingKey - TradingKey
MSN Money - MSN
Number of shareholders of Microbot Medical Inc. – NASDAQ:MBOT - TradingView
Microbot Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - MarketBeat
Microbot Medical’s LIBERTY System Gains Early Market Traction - TipRanks
Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites - marketscreener.com
A blood-vessel robot lands 2 trial sites as its rollout expands - Stock Titan
Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites - TradingView
Microbot wins multiple LIBERTY system accounts, including two ACCESS-PVI trial sites - TradingView
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites - marketscreener.com
Microbot Medical (MBOT) gains new LIBERTY robotic adopters post-SIR - Stock Titan
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen - MarketBeat
Microbot Medical Inc (MBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.16%
0.04%
자본화:
|
볼륨(24시간):